Login / Signup
Hiroaki Yaoi
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Patient Reported Outcomes
Ejection Fraction
Top Venues
Haemophilia : the official journal of the World Federation of Hemophilia
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hiroaki Yaoi
,
Yasuaki Shida
,
Kenichi Ogiwara
,
Takehisa Kitazawa
,
Midori Shima
,
Keiji Nogami
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia
28 (5) (2022)